Vitaris fined in Morocco over merger notification, sources say

Reuters11-21

By Ahmed Eljechtimi

RABAT, Nov 21 (Reuters) - U.S. pharmaceutical giant Viatris Inc has been fined 7.58 million dirhams ($760,000) by Morocco's competition regulator for failing to notify it regarding its merger, two official sources said on Thursday.

Viatris was formed by the merger of Mylan, which has a subsidiary in Morocco, and Pfizer's Upjohn business in 2020.

The fine, equivalent to 2.5% Viatris; revenue in Morocco last year, has already been paid to the Moroccan treasury, the sources said, requesting anonymity.

Viatris also declined to appeal the decision, the sources said.

Viatris did not immediately respond to a Reuters emailed request for comment.

The regulator is examining other mergers where Moroccan authorities have not been notified, one of the sources said.

(Reporting by Ahmed Eljechtimi; editing by Jason Neely)

((ahmed.eljechtimi@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment